Individuals with liver fibrosis exhibit higher plasma levels of inflammatory and haemostatic factors, hyperuricaemia, lower circulating insulin-like growth factor-1 levels, endothelial dysfunction, and biomarkers of oxidative stress that lead to poor outcomes such as cardiovascular disease (24–27). This evidence concerns the gene IGF1 and Hepatic fibrosis.